| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2019 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $47.50 | $285,000.00 | -17.4% | |
| Nov 14, 2019 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $34.64 | $389,727.00 | -2.6% | |
| Nov 7, 2019 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $38.27 | $229,624.22 | -9.3% | |
| Oct 9, 2019 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $36.68 | $412,676.25 | -2.6% | |
| Oct 7, 2019 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $36.73 | $220,380.00 | -17.4% | |
| Sep 20, 2019 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $40.16 | $451,818.75 | -2.6% | |
| Sep 17, 2019 | Cotroneo Pat | SVP, Finance And CFO | Sell | 3,201 | $41.38 | $132,457.38 | -1.3% | |
| Sep 16, 2019 | Yu K Peony | Chief Medical Officer | Sell | 3,419 | $40.92 | $139,905.48 | -1.9% | |
| Sep 9, 2019 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $40.95 | $245,723.40 | -9.5% | |
| Aug 23, 2019 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $43.17 | $485,682.16 | -1.5% |